THE NATIONAL RESEARCH ONCOLOGY CENTER
Kazakhstan is building an oncology treatment and research center to serve the Eurasian region. With more than 30,000 new cases of cancer diagnosed annually in Kazakhstan — and more than half at a late stage — this initiative is vital. The National Research Oncology Center (NROC) will be a Cancer Institute housing some of the most advanced technologies and clinical applications for enhanced oncology care, including stereotactic radiosurgery, 3.0T MRI, and disease-based clinical pathways to improve health and wellbeing throughout Kazakhstan. The Institute will include 100 acute care beds and a 150-bed family house, allowing for the flexibility of keeping radiation oncology and chemotherapy patients near the facility during their course of treatment without the cost of traditional inpatient beds. NROC will also host educational events and clinical trials.
Under the management of Nazarbayev University’s National Medical Holdings, the government-funded National Research Oncology Center will include:
- A hospital
- Outpatient care
- A research facility
- A hotel complex
PARTNERSHIP WITH NAZARBAYEV UNIVERSITY
In partnership with Nazarbayev University, UPMC assessed the types of oncology services needed in Kazakhstan and developed a national cancer center in the capital of Astana. The center will incorporate the tactics used by UPMC to successfully integrate care, research, and medical education at UPMC CancerCenter and its more than 35 locations in western Pennsylvania, Ireland, and Italy. In partnership with the University of Pittsburgh Cancer Institute (UPCI), the only National Cancer Institute-designated comprehensive cancer center in western Pennsylvania, UPMC CancerCenter accelerates research breakthroughs into clinical practice around the world.
UPMC is an integrated global health enterprise headquartered in Pittsburgh, Pennsylvania, and is one of the leading health systems in the United States. With more than 3,200 physicians, 20 hospitals, and a myriad of community-based facilities and outpatient programs serving 29 counties in western Pennsylvania, UPMC is the leading provider of health care services in the region, providing the highest level of clinical care to the 74,000 individuals receiving services at its facilities each year. UPMC is the only medical center in the western Pennsylvania region to be ranked No.10 among thousands of eligible hospitals nationwide in U.S. News & World Report Honor Roll of America’s Best Hospitals, No. 25 in cancer care nationally in 2013.
UPMC is creating an international medical, research, and academic network, providing patients with access to world-class health care close to home. Bringing leading-edge health care, advanced technologies, and management skills to markets throughout the world, UPMC is continually seeking new partners. Through advisory services, infrastructure consultation, and clinical management, UPMC is helping to transform health care throughout communities in:
- Ireland: Cancer center
- Italy: Transplantation, radiotherapy, and biotechnology centers
- United Kingdom: Information technology and cancer care
- Kazakhstan: Oncology center consults
- Singapore: Transplantation and clinical management
- China: Pathology consults and health care collaboration
- Japan: Education in primary care and family medicine
UMPC is taking health care from where it is to where it needs to be by creating a future built on ideas, innovation, and care. An industry leader, UPMC exports excellence nationally and internationally while fueling the development of new businesses that leverage our intellectual capital, core capabilities, and management expertise. A catalyst for regional economic renaissance, UPMC remains steadfastly committed to a meaningful combination of premier health care services and dedicated clinical personnel to contribute a positive transformation in the regions we serve.